| 1599440-13-7 Basic information More.. |
Product Name: | Deruxtecan | Synonyms: | Deruxtecan analog;Glycinamide, N-[6-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-1-oxohexyl]glycylglycyl-L-phenylalanyl-N-[[2-[[(1S,9S)-9-ethyl-5-fluoro-2,3,9,10,13,15-hexahydro-9-hydroxy-4-methyl-10,13-dioxo-1H,12H-benzo[de]pyrano[3',4':6,7]indolizino[1,2-b]quinolin-1-yl]amino]-2-oxoethoxy]methyl]-;MC-GGFG-Exetecan;Deruxtecan;Deruxtecan(DX-8951);N-((S)-10-Benzyl-1-(((1S,9S)-9-ethyl-5-fluoro-9-hydroxy-4-methyl-10,13-dioxo-2,3,9,10,13,15-hexahydro-1H,12H-benzo[de]pyrano[3',4':6,7]indolizino[1,2-b]quinolin-1-yl)amino)-1,6,9,12,15-pentaoxo-3-oxa-5,8,11,14-tetraazahexadecan-16-yl)-6-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)hexanamide;Drug-Linker Conjugates for ADC,Inhibitor,inhibit,Deruxtecan;Ibandronate Impurity 32 | CAS: | 1599440-13-7 | MF: | C52H56FN9O13 | MW: | 1034.05 | EINECS: | | Mol File: | 1599440-13-7.mol | |
Use
Deruxtecan is an ADC drug-linker conjugate composed of a derivative of DX-8951 (DXd) and a maleimide-GGFG peptide linker, used for synthesizing DS-8201 and U3-1402.
- Deruxtecan
-
- US $139.00-497.00 / mg
- 2024-11-01
- CAS:1599440-13-7
- Min. Order:
- Purity: 98.20%
- Supply Ability: 10g
- Deruxtecan
-
- US $0.00-0.00 / KG
- 2022-10-14
- CAS:1599440-13-7
- Min. Order: 1KG
- Purity: 98%
- Supply Ability: 1Ton
- Deruxtecan
-
- US $4666.00 / mg/bottle
- 2022-03-07
- CAS:1599440-13-7
- Min. Order: 100mg/bottle
- Purity: 99%
- Supply Ability: 10kg
|
1599440-13-7
Recommend Suppliers |
|